Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 2Active not recruiting 2Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 302Carcinoma, Non-Small-Cell Lung 237Prostatic Neoplasms 194Neoplasms 186Lung Neoplasms 145Multiple Myeloma 140Neoplasm Metastasis 107Colorectal Neoplasms 104Melanoma 93Ovarian Neoplasms 88Leukemia, Myeloid, Acute 80Pancreatic Neoplasms 77Lymphoma 73Leukemia, Lymphocytic, Chronic, B-Cell 69Brain Neoplasms 67Carcinoma, Renal Cell 66Lymphoma, Non-Hodgkin 64Squamous Cell Carcinoma of Head and Neck 62Carcinoma, Hepatocellular 59Urinary Bladder Neoplasms 58Hematologic Neoplasms 57Recurrence 56Head and Neck Neoplasms 56Triple Negative Breast Neoplasms 55Glioblastoma 52Endometrial Neoplasms 51Lymphoma, Follicular 50Uterine Cervical Neoplasms 49Sarcoma 46Precursor Cell Lymphoblastic Leukemia-Lymphoma 46

Interventions

Tablets 1Fulvestrant 1Alpelisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Genetic Diseases, Inborn × 90 days × Clear all
NCT06089954 2026-05-26

ROR

Abramson Cancer Center at Penn Medicine

Phase NA Active not recruiting
2,500 enrolled

Cardiovascular Diseases, Neoplasms, Genetic Diseases, Inborn

NCT05392608 2026-05-22

SEQUEL-Breast

Borstkanker Onderzoek Groep

Phase 2 Active not recruiting
130 enrolled
Breast

Breast Neoplasms, Genetic Diseases, Inborn

Data powered by HemOnc (CC BY 4.0) Colophon âš¡